147 related articles for article (PubMed ID: 18297539)
1. JAK2 exon 12 mutation in JAK2V617F-negative polycythemia vera.
Röthlisberger B; Huber A; Bargetzi M; Mendez A; Heizmann M
Leuk Lymphoma; 2008 Mar; 49(3):586-8. PubMed ID: 18297539
[No Abstract] [Full Text] [Related]
2. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.
Schnittger S; Bacher U; Haferlach C; Geer T; Müller P; Mittermüller J; Petrides P; Schlag R; Sandner R; Selbach J; Slawik HR; Tessen HW; Wehmeyer J; Kern W; Haferlach T
Haematologica; 2009 Mar; 94(3):414-8. PubMed ID: 19252176
[TBL] [Abstract][Full Text] [Related]
3. Apparent 'JAK2-negative' polycythaemia vera due to compound mutations in exon 14.
Tiong IS; Casolari DA; Moore S; Nguyen T; Van Velzen MJM; Zantomio D; Scott HS; D'Andrea RJ; Hahn CN; Ross DM
Br J Haematol; 2017 Jul; 178(2):333-336. PubMed ID: 27136492
[No Abstract] [Full Text] [Related]
4. The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera.
Olcaydu D; Skoda RC; Looser R; Li S; Cazzola M; Pietra D; Passamonti F; Lippert E; Carillo S; Girodon F; Vannucchi A; Reading NS; Prchal JT; Ay C; Pabinger I; Gisslinger H; Kralovics R
Leukemia; 2009 Oct; 23(10):1924-6. PubMed ID: 19440215
[No Abstract] [Full Text] [Related]
5. Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients.
Kouroupi E; Zoi K; Parquet N; Zoi C; Kiladjian JJ; Grigoraki V; Vainchenker W; Lellouche F; Marzac C; Schlageter MH; Dosquet C; Scott LM; Fenaux P; Loukopoulos D; Chomienne C; Cassinat B
Br J Haematol; 2008 Aug; 142(4):676-9. PubMed ID: 18503583
[No Abstract] [Full Text] [Related]
6. Infrequent occurrence of MPL exon 10 mutations in polycythemia vera and post-polycythemia vera myelofibrosis.
Pardanani A; Lasho TL; Finke CM; Tefferi A
Am J Hematol; 2011 Aug; 86(8):701-2. PubMed ID: 21674576
[No Abstract] [Full Text] [Related]
7. Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients.
Butcher CM; Hahn U; To LB; Gecz J; Wilkins EJ; Scott HS; Bardy PG; D'Andrea RJ
Leukemia; 2008 Apr; 22(4):870-3. PubMed ID: 17914411
[No Abstract] [Full Text] [Related]
8. Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.
Pardanani A; Lasho TL; Finke C; Hanson CA; Tefferi A
Leukemia; 2007 Sep; 21(9):1960-3. PubMed ID: 17597810
[TBL] [Abstract][Full Text] [Related]
9. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
10. JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease.
Tefferi A; Lavu S; Mudireddy M; Lasho TL; Finke CM; Gangat N; Pardanani A; Hanson CA; Mannarelli C; Guglielmelli P; Vannucchi AM
Am J Hematol; 2018 Aug; 93(4):E93-E96. PubMed ID: 29274140
[No Abstract] [Full Text] [Related]
11. Coexistence of gain-of-function JAK2 germ line mutations with JAK2V617F in polycythemia vera.
Lanikova L; Babosova O; Swierczek S; Wang L; Wheeler DA; Divoky V; Korinek V; Prchal JT
Blood; 2016 Nov; 128(18):2266-2270. PubMed ID: 27647865
[No Abstract] [Full Text] [Related]
12. High percentage of JAK2 exon 12 mutation in Asian patients with polycythemia vera.
Yeh YM; Chen YL; Cheng HY; Su WC; Chow NH; Chen TY; Ho CL
Am J Clin Pathol; 2010 Aug; 134(2):266-70. PubMed ID: 20660330
[TBL] [Abstract][Full Text] [Related]
13. Detection of JAK2 Exon 12 Mutations in JAK2 V617F-Negative Polycythemia Vera Patients by Cloning Technique.
Leszczynska A; Grzenkowicz-Wydra J; Chmielewska-Gorycka L; Bieniaszewska M; Hellmann A
Acta Haematol; 2016; 136(2):123-8. PubMed ID: 27410038
[TBL] [Abstract][Full Text] [Related]
14. Ruxolitinib in a Child With JAK2 Exon 12 Mutant Polycythemia Vera.
Stoops K; Kuril S
J Pediatr Hematol Oncol; 2023 May; 45(4):e502-e505. PubMed ID: 36161965
[TBL] [Abstract][Full Text] [Related]
15. The JAK2 exon 12 mutations: a comprehensive review.
Scott LM
Am J Hematol; 2011 Aug; 86(8):668-76. PubMed ID: 21674578
[TBL] [Abstract][Full Text] [Related]
16. A novel JAK2 exon 12 mutation identified in the retrospective analysis of paraffin-embedded tissues of polycythemia vera patients.
Burjanivova T; Marcinek J; Lasabova Z; Minarik G; Szepe P; Balharek T; Vanochova A; Polacek H; Plank L
Diagn Mol Pathol; 2009 Jun; 18(2):108-11. PubMed ID: 19430293
[TBL] [Abstract][Full Text] [Related]
17. The role of a low erythropoietin level in the diagnosis of JAK2 exon 12-mutated polycythemia vera.
Langabeer SE
Blood Cells Mol Dis; 2020 Feb; 80():102377. PubMed ID: 31655393
[No Abstract] [Full Text] [Related]
18. Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With JAK2V617F-negative Polycythemia Vera.
Khosravi S; Chahardouli B; Ebrahimi P; Babaei FN; Alimoghadam K; Rostami S
Hematol Oncol Stem Cell Ther; 2024 Mar; 17(2):154-158. PubMed ID: 38560972
[No Abstract] [Full Text] [Related]
19. Resolution of thrombocytopenia, but not polycythemia after ruxolitinib for polycythemia vera with detectable mutation in the exon 12 of the JAK2 gene.
Helbig G; Wichary R; Torba K; Kyrcz-Krzemień S
Med Oncol; 2017 Mar; 34(3):31. PubMed ID: 28120162
[No Abstract] [Full Text] [Related]
20. A resequencing program in India detects the rare JAK2 L579F mutation in patients suffering from polycythemia vera and negative for JAK2 V617F.
Acharya A; Vaniawala S; Parekh H; Sheikh H; Patel H; Ali R; Khan A; Nagee A; Kunjadia P; Mukhopadhyaya PN
Int J Lab Hematol; 2014 Aug; 36(4):e30-3. PubMed ID: 24033912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
